Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,428 | -3,308 | -3,390 | N/A | N/A |
| Depreciation Amortization | 476 | 285 | 210 | N/A | N/A |
| Accounts receivable | -359 | -88 | N/A | N/A | N/A |
| Other Working Capital | 557 | -518 | -90 | N/A | N/A |
| Other Operating Activity | 423 | 384 | 40 | 0 | 0 |
| Operating Cash Flow | $-4,331 | $-3,245 | $-3,230 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,394 | N/A | N/A | N/A | N/A |
| PPE Investments | -72 | -5 | 5 | N/A | N/A |
| Net Acquisitions | N/A | -102 | -100 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 5 | 0 | 0 |
| Investing Cash Flow | $-17,466 | $-107 | $-90 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,615 | N/A | N/A | N/A | N/A |
| Debt Repayment | -26 | -97 | N/A | N/A | N/A |
| Common Stock Repurchased | -754 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 17,508 | 2,831 | 4,380 | 0 | 0 |
| Financing Cash Flow | $29,343 | $2,734 | $4,380 | $N/A | $N/A |
| Beginning Cash Position | 869 | 1,487 | 430 | N/A | N/A |
| End Cash Position | 8,415 | 869 | 1,480 | N/A | N/A |
| Net Cash Flow | $7,546 | $-618 | $1,040 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,331 | -3,245 | -3,230 | N/A | N/A |
| Capital Expenditure | -72 | -5 | N/A | N/A | N/A |
| Free Cash Flow | -4,403 | -3,250 | -3,230 | 0 | 0 |